Guanjie Qin
15 Lequn Road
Guilin, 541001, China
Guilin, 541001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy and Safety of Vascular-Targeting Agents Plus Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients: A Multicenter Clinical Cohort Study.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: September 29, 2025
An individualized immune prognostic signature in nasopharyngeal carcinoma.
Journal: Oral oncology
Published: May 12, 2024
Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: February 08, 2024
Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study.
Journal: Frontiers in immunology
Published: September 21, 2023
Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma : A prospective multicenter phase II trial.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: June 14, 2023
Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma.
Journal: Pathology, research and practice
Published: April 28, 2023
Hypofractionated radiotherapy compared with conventionally fractionated radiotherapy to treat initial distant metastases in nasopharyngeal carcinoma: A multicenter, prospective, randomized, phase II trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 11, 2022
Building Practical Risk Prediction Models for Nasopharyngeal Carcinoma Screening with Patient Graph Analysis and Machine Learning.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: July 15, 2022
Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: November 03, 2021
MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2.
Journal: Cell death & disease
Published: October 15, 2021
Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
Journal: Oral oncology
Published: November 17, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026